The US Food and Drug Administration (FDA) will make its final decision on whether to approve aducanumab, Biogen’s Alzheimer’s disease drug, by next Tuesday. The…
March 24, 2023
The Healthcare News Platform
The US Food and Drug Administration (FDA) will make its final decision on whether to approve aducanumab, Biogen’s Alzheimer’s disease drug, by next Tuesday. The…